Please enable JavaScript to continue using this application.

Compare $IMNN vs $VSBC | Chartloom

Compare

$IMNN vs $VSBC

Imunon Inc · Vitaspring Biomedical Co. Ltd

IMNN

Imunon Inc

VSBC

Vitaspring Biomedical Co. Ltd

Compare $IMNN vs $VSBC

Comparing Imunon Inc and Vitaspring Biomedical Co. Ltd

IMNNImunon Inc

VSBCVitaspring Biomedical Co. Ltd

IMNNImunon Inc

Market cap

$5M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-72.7%

52W performance

-79.7%

FCF yield

-334.7%

VSBCVitaspring Biomedical Co. Ltd

Market cap

$7M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-100.0%

52W performance

-100.0%

FCF yield

0.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IMNN

VSBC

Detailed metrics comparison

IMNN

Imunon Inc

VSBC

Vitaspring Biomedical Co. Ltd

Market Cap

IMNN$5M

VSBC$7M

Enterprise Value

IMNN$5M

VSBC$9M

Price

IMNN$1.08

VSBC$0.00

P/E Ratio

IMNNN/A

VSBCN/A

P/S Ratio

IMNN13.81x

VSBC0.99x

EV/Sales

IMNN14.14x

VSBC0.99x

EV/EBITDA

IMNN0.00x

VSBC4.29x

P/B Ratio

IMNN1.71x

VSBC3.92x

P/FCF Ratio

IMNNN/A

VSBC765.53x

EV/FCF

IMNN-0.31x

VSBC1,044.32x

PEG Ratio

IMNNN/A

VSBCN/A

Forward P/E (NTM)

IMNNN/A

VSBCN/A

Forward P/S (NTM)

IMNNN/A

VSBCN/A

Revenue (TTM)

IMNN$0

VSBC$0

Revenue Growth (YoY)

IMNNN/A

VSBCN/A

Forward Rev Growth

IMNN205.5%

VSBC0.0%

Gross Margin (TTM)

IMNN34.1%

VSBC39.3%

Operating Margin (TTM)

IMNN0.0%

VSBC23.4%

EBITDA Margin (TTM)

IMNN0.0%

VSBC0.0%

Net Margin (TTM)

IMNN0.0%

VSBC18.2%

FCF Margin (TTM)

IMNNN/A

VSBCN/A

Net Income (TTM)

IMNN$-15M

VSBC$-456K

FCF (TTM)

IMNN$-15M

VSBC$9K

EPS (TTM)

IMNN-$2.82

VSBC-$0.00

ROE (TTM)

IMNN-31490.0%

VSBC70.0%

ROA (TTM)

IMNN-13292.0%

VSBC-211240.0%

ROIC (TTM)

IMNN-22880.0%

VSBC70.0%

Cash

IMNN$7M

VSBC$13K

Debt

IMNN$7M

VSBC$2M

Net Cash/Debt

IMNN$-170K

VSBC$-2M

Current Ratio (TTM)

IMNN1.82x

VSBC0.00x

Quick Ratio (TTM)

IMNN1.44x

VSBC0.00x

Debt/Equity (TTM)

IMNN1.68x

VSBC0.00x

Debt/Assets (TTM)

IMNN0.0%

VSBC0.0%

Interest Coverage (TTM)

IMNNN/A

VSBCN/A

Net Debt/EBITDA (TTM)

IMNN0.00x

VSBC0.00x

Beta

IMNN2.08

VSBC-1.25

52W Performance

IMNN-79.7%

VSBC-100.0%

YTD Performance

IMNN-72.7%

VSBC-100.0%

% from 52W High

IMNN-80.0%

VSBC-100.0%

% from 52W Low

IMNN12.5%

VSBCN/A

Asset Turnover (TTM)

IMNN0.01x

VSBC2.66x

FCF Yield (TTM)

IMNN-334.7%

VSBC0.1%

Earnings Yield (TTM)

IMNN-324.8%

VSBC-6.9%

Dividend Yield (TTM)

IMNNN/A

VSBCN/A

Rule of 40

IMNN0.0

VSBC0.0

EV/GP/RG

IMNNN/A

VSBCN/A

Ticker research

View IMNN research View VSBC research

Metric	IMNN Imunon Inc	VSBC Vitaspring Biomedical Co. Ltd
Market & Valuation
Market Cap	$5M	$7M
Enterprise Value	$5M	$9M
Price	$1.08	$0.00
P/E Ratio	N/A	N/A
P/S Ratio	13.81x	0.99x
EV/Sales	14.14x	0.99x
EV/EBITDA	0.00x	4.29x
P/B Ratio	1.71x	3.92x
P/FCF Ratio	N/A	765.53x
EV/FCF	-0.31x	1,044.32x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	205.5%	0.0%
Profitability
Gross Margin (TTM)	34.1%	39.3%
Operating Margin (TTM)	0.0%	23.4%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	18.2%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-15M	$-456K
FCF (TTM)	$-15M	$9K
EPS (TTM)	-$2.82	-$0.00
ROE (TTM)	-31490.0%	70.0%
ROA (TTM)	-13292.0%	-211240.0%
ROIC (TTM)	-22880.0%	70.0%
Financial Health
Cash	$7M	$13K
Debt	$7M	$2M
Net Cash/Debt	$-170K	$-2M
Current Ratio (TTM)	1.82x	0.00x
Quick Ratio (TTM)	1.44x	0.00x
Debt/Equity (TTM)	1.68x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.08	-1.25
52W Performance	-79.7%	-100.0%
YTD Performance	-72.7%	-100.0%
% from 52W High	-80.0%	-100.0%
% from 52W Low	12.5%	N/A
Efficiency & Yields
Asset Turnover (TTM)	0.01x	2.66x
FCF Yield (TTM)	-334.7%	0.1%
Earnings Yield (TTM)	-324.8%	-6.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View IMNN research	View VSBC research

Valuation

P/S Ratio

VSBC

0.99x

IMNN

13.81x

EV/FCF

IMNN

-0.31x

VSBC

1,044.32x

Growth & revenue

Forward Revenue Growth

IMNN

205.5%

VSBC

0.0%

Profitability & performance

Gross Margin

VSBC

39.3%

IMNN

34.1%

ROE

VSBC

70.0%

IMNN

-31490.0%

FCF Yield %

VSBC

0.1%

IMNN

-334.7%

52-Week Performance

IMNN

-79.7%

VSBC

-100.0%

Detailed metrics comparison

IMNN

Imunon Inc

VSBC

Vitaspring Biomedical Co. Ltd

Market Cap

IMNN$5M

VSBC$7M

Enterprise Value

IMNN$5M

VSBC$9M

Price

IMNN$1.08

VSBC$0.00

P/E Ratio

IMNNN/A

VSBCN/A

P/S Ratio

IMNN13.81x

VSBC0.99x

EV/Sales

IMNN14.14x

VSBC0.99x

EV/EBITDA

IMNN0.00x

VSBC4.29x

P/B Ratio

IMNN1.71x

VSBC3.92x

P/FCF Ratio

IMNNN/A

VSBC765.53x

EV/FCF

IMNN-0.31x

VSBC1,044.32x

PEG Ratio

IMNNN/A

VSBCN/A

Forward P/E (NTM)

IMNNN/A

VSBCN/A

Forward P/S (NTM)

IMNNN/A

VSBCN/A

Revenue (TTM)

IMNN$0

VSBC$0

Revenue Growth (YoY)

IMNNN/A

VSBCN/A

Forward Rev Growth

IMNN205.5%

VSBC0.0%

Gross Margin (TTM)

IMNN34.1%

VSBC39.3%

Operating Margin (TTM)

IMNN0.0%

VSBC23.4%

EBITDA Margin (TTM)

IMNN0.0%

VSBC0.0%

Net Margin (TTM)

IMNN0.0%

VSBC18.2%

FCF Margin (TTM)

IMNNN/A

VSBCN/A

Net Income (TTM)

IMNN$-15M

VSBC$-456K

FCF (TTM)

IMNN$-15M

VSBC$9K

EPS (TTM)

IMNN-$2.82

VSBC-$0.00

ROE (TTM)

IMNN-31490.0%

VSBC70.0%

ROA (TTM)

IMNN-13292.0%

VSBC-211240.0%

ROIC (TTM)

IMNN-22880.0%

VSBC70.0%

Cash

IMNN$7M

VSBC$13K

Debt

IMNN$7M

VSBC$2M

Net Cash/Debt

IMNN$-170K

VSBC$-2M

Current Ratio (TTM)

IMNN1.82x

VSBC0.00x

Quick Ratio (TTM)

IMNN1.44x

VSBC0.00x

Debt/Equity (TTM)

IMNN1.68x

VSBC0.00x

Debt/Assets (TTM)

IMNN0.0%

VSBC0.0%

Interest Coverage (TTM)

IMNNN/A

VSBCN/A

Net Debt/EBITDA (TTM)

IMNN0.00x

VSBC0.00x

Beta

IMNN2.08

VSBC-1.25

52W Performance

IMNN-79.7%

VSBC-100.0%

YTD Performance

IMNN-72.7%

VSBC-100.0%

% from 52W High

IMNN-80.0%

VSBC-100.0%

% from 52W Low

IMNN12.5%

VSBCN/A

Asset Turnover (TTM)

IMNN0.01x

VSBC2.66x

FCF Yield (TTM)

IMNN-334.7%

VSBC0.1%

Earnings Yield (TTM)

IMNN-324.8%

VSBC-6.9%

Dividend Yield (TTM)

IMNNN/A

VSBCN/A

Rule of 40

IMNN0.0

VSBC0.0

EV/GP/RG

IMNNN/A

VSBCN/A

Ticker research

View IMNN research View VSBC research

Metric	IMNN Imunon Inc	VSBC Vitaspring Biomedical Co. Ltd
Market & Valuation
Market Cap	$5M	$7M
Enterprise Value	$5M	$9M
Price	$1.08	$0.00
P/E Ratio	N/A	N/A
P/S Ratio	13.81x	0.99x
EV/Sales	14.14x	0.99x
EV/EBITDA	0.00x	4.29x
P/B Ratio	1.71x	3.92x
P/FCF Ratio	N/A	765.53x
EV/FCF	-0.31x	1,044.32x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	205.5%	0.0%
Profitability
Gross Margin (TTM)	34.1%	39.3%
Operating Margin (TTM)	0.0%	23.4%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	18.2%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-15M	$-456K
FCF (TTM)	$-15M	$9K
EPS (TTM)	-$2.82	-$0.00
ROE (TTM)	-31490.0%	70.0%
ROA (TTM)	-13292.0%	-211240.0%
ROIC (TTM)	-22880.0%	70.0%
Financial Health
Cash	$7M	$13K
Debt	$7M	$2M
Net Cash/Debt	$-170K	$-2M
Current Ratio (TTM)	1.82x	0.00x
Quick Ratio (TTM)	1.44x	0.00x
Debt/Equity (TTM)	1.68x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.08	-1.25
52W Performance	-79.7%	-100.0%
YTD Performance	-72.7%	-100.0%
% from 52W High	-80.0%	-100.0%
% from 52W Low	12.5%	N/A
Efficiency & Yields
Asset Turnover (TTM)	0.01x	2.66x
FCF Yield (TTM)	-334.7%	0.1%
Earnings Yield (TTM)	-324.8%	-6.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View IMNN research	View VSBC research